Pilianidis, G. et al. 2024. Can euglycemic diabetic ketoacidosis caused by SGLT2 inhibitors be avoided in COVID-19 and other acute infections? European Journal of Case Reports in Internal Medicine. 11, 3 (Feb. 2024). DOI:https://doi.org/10.12890/2024_004282.